Navigation Links
ThermoGenesis Presentation at Rodman & Renshaw Conference
Date:11/7/2008

RANCHO CORDOVA, Calif., Nov. 7 /PRNewswire-FirstCall/ -- ThermoGenesis Corp. (Nasdaq: KOOL), a leading supplier of innovative products that process and store adult stem cells, announced today that it will be participating in the Rodman & Renshaw 10th Annual Healthcare Conference on Monday, November 10, 2008.

The Company's presentation by Dr. William Osgood, the Company's CEO, will begin at 2:50 p.m., Eastern Standard Time (11:50 am, Pacific Standard Time), and will be held at the New York Palace Hotel, located at 455 Madison Ave., New York, NY 10022.

Webcast

The presentation will be webcast LIVE and archived for 90 days, streaming video and PowerPoint slides. Access is available by logging on to the conference website http://www.wsw.com/webcast/rrshq14/kool or by going to the Company's website http://www.thermogenesis.com. It is recommended that interested parties register at least 15 minutes prior to the start of the presentation to ensure timely access.

About ThermoGenesis Corp.

ThermoGenesis Corp. (http://www.thermogenesis.com) is a leading supplier of innovative products and services that process and store adult stem cells for treatment of disease and injury.

ThermoGenesis Corp.

Web site: http://www.thermogenesis.com

Contact: Investor Relations

+1-916-858-5107, or

ir@thermogenesis.
'/>"/>

SOURCE ThermoGenesis Corp.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. ThermoGenesis Corp. to Announce Fourth Quarter and Year End Results for Fiscal Year 2007 on September 12, 2007
2. ThermoGenesis Corp. Reports Fourth Quarter and Fiscal Year 2007 Results
3. ThermoGenesis Corp. to Present at 2007 Global Life Sciences Conference on Thursday, September 27, 2007
4. ThermoGenesis Corp. to Announce First Quarter Fiscal 2008 Results on November 8, 2007
5. ThermoGenesis Corp. to Announce Second Quarter Fiscal 2008 Results on February 6, 2008
6. ThermoGenesis Corp. Reports 48 Percent Growth in Second Quarter Revenues Year Over Year
7. ThermoGenesis Corp. Announces Voluntary Recall of Selected Lots of AXP Bag Sets
8. ThermoGenesis Subsidiary Vantus Announces Stem Cell Agreement With UC Davis Center For Equine Health
9. ThermoGenesis Names Dr. Mahendra Rao to Board of Directors
10. ThermoGenesis Announces Receipt of CE Mark for MarrowXpress(TM)
11. ThermoGenesis Announces FDA Authorization to Market MarrowXpress(TM) (MXP(TM))

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)...A, Va., Nov. 9 CEL-SCI C... Dr. Kenneth S. Rosenthal, Professor of Immunology...s College of Medicine and Pharmacy, reported on wo...he Cleveland Clinic and CEL-SCI on CEL-SCI,s LEAPS...e 7th GTCbio Vaccine: "All Things Considered" Conf...
(Date:11/8/2009)...UNTAIN VIEW, Calif. Nov. 5, 2009 Complete Genomi...pany, today announced publication of a report in t...A sequencing platform, including analysis of seque...nsumables cost for these three genomes sequenced o...nged from $8,005 for 87x coverage to $1,726 for 45...
(Date:11/6/2009)...Y, Mass., Nov. 6 Myriant Technolog...eloper and manufacturer of renewable bio-chemical...echnology provider Uhde GmbH, one of the world,s l...nnounced an alliance for the engineering, procurem... Succinic Acid plants based on renewable feedstock...
(Date:11/6/2009)...RD, Calif., Nov. 6 Intarcia Therap...its ITCA 650 (DUROS® continuous delivery of e...etes at the Ninth Annual Diabetes Technology Meeti...newscom.com/cgi-bin/prnh/20050301/SFTU126LOGO ) ,...e Via ITCA 650 Lowers Plasma Glucose, HbA1c and Re...
Breaking Biology Technology:CEL-SCI Collaborators Present Data Suggesting That LEAPS Technology Has Ability to Modify Immune Response 2CEL-SCI Collaborators Present Data Suggesting That LEAPS Technology Has Ability to Modify Immune Response 3Complete Genomics publishes in Science on low-cost sequencing of 3 human genomes 2Myriant Technologies LLC, Uhde Corporation of America and Uhde GmbH Announce Alliance for Engineering, Procurement & Construction of World Scale Renewable Succinic Acid Plants 2Myriant Technologies LLC, Uhde Corporation of America and Uhde GmbH Announce Alliance for Engineering, Procurement & Construction of World Scale Renewable Succinic Acid Plants 3Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 2Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 3Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 4Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 5
... Neurobiological,Technologies, Inc. (NTI(R)) (Nasd...07, the Company received notification from the NAS...ot in compliance with the $35 million,market value...sting on The,NASDAQ Capital Market set forth in NA... with Marketplace Rule 4310(c)(8)(C), the Company ...
... for Sept. 3, UPPSALA, Sweden and WILMINGTON, Mas...de Bruyne, M.D., Ph.D., will present the,benefits ... Reserve (FFR),in improving the outcomes of multiv... Cardiology (ESC) Congress 2007 in Vienna. The EBA...Medical Systems, will take place at,12:45 p.m. CES...
...erenium,Corporation (Nasdaq: VRNM ), a leading de...neer in the development of high-performance specia...President and Chief Executive,Officer of Verenium,...,Energy Conference. The presentation is scheduled ... 2007 and will take place at Le Parker Meridien in...
Other Biology Technology:Neurobiological Technologies, Inc. Reports Receipt of Notice From Nasdaq 2Interventional Cardiologists Nico Pijls, Bernard De Bruyne to Discuss Benefits of Measuring Coronary Pressure in Improving Multivessel PCI at ESC Congress 2007 2Verenium Corporation to Present at the Upcoming Cowen and Company Clean Energy Conference 2Verenium Corporation to Present at the Upcoming Cowen and Company Clean Energy Conference 3
(Date:11/9/2009)...e University evolutionary biologists David Queller...h cooperation and low conflict between components,... its "organismality," whether that thing is an ani... the traits scientists use to describe an organism...same species, may not be necessary to achieve orga...
(Date:11/9/2009)... PALO ALTO, Calif., Nov. 9 Genenco...stainable Energy Award" from the American Institut...e® family of enzymes for cellulosic ethanol. ... committee, presented the award to Landon Steele, ...ellerase® Product Manager, and Aaron Kelley, ...
(Date:11/9/2009)...LADELPHIA, NOVEMBER 9, 2009 A nutritionist whose...getables to the federal Women, Infants and Childre...es Agnes Higgins Award for outstanding achievement...ail Harrison, Ph.D., MNS, , a professor in the Dep...sity of California, Los Angeles School of Public H...
Breaking Biology News(10 mins):What is the meaning of 'one'? 2What is the meaning of 'one'? 3Genencor Wins The American Institute of Chemical Engineers (AIChE) Sustainable Energy Award For Accellerase(R) Cellulosic Ethanol Enzymes 2March of Dimes honors Dr. Gail Harrison for outstanding work in maternal-fetal nutrition 2Summa Health System Creates Quick Win With Their Caregiver Community By Implementing Sentillions Clinical Workstation Solution 53221 1Summa Health System Creates Quick Win With Their Caregiver Community By Implementing Sentillions Clinical Workstation Solution 53221 2Summa Health System Creates Quick Win With Their Caregiver Community By Implementing Sentillions Clinical Workstation Solution 53221 3Air Methods to Report Second Quarter Financial Results After Market Close on Thursday August 6 2009 53219 1Medicagos H1N1 pandemic vaccine candidate shows positive response in 100 25 of vaccinated animals after a single dose 13289 1Medicagos H1N1 pandemic vaccine candidate shows positive response in 100 25 of vaccinated animals after a single dose 13289 2Medicagos H1N1 pandemic vaccine candidate shows positive response in 100 25 of vaccinated animals after a single dose 13289 3
...altimore, MDStem cells are the body,s primal cells...ore specialized types of cells over many cycles of...he Carnegie Institution have identified a gene, na...eping a variety of stem cells in their undifferent... their potency has implications both for our knowl...
...EW YORK, Jan. 6, 2009 Scientists have discovered ...unrelated bacterial species, a finding that raises...g of toxins and other disease-aiding factors may b...oratory experiment, the scientists from NYU School..., a notorious bacterium that causes toxic shock sy...
...INCINNATI Mutation of a gene that helps proteins ...enter the nucleus puts some families at higher r...tizing encephalopathy (ANE). , This is the conclu...he American Journal of Human Genetics , and curre...rom Cincinnati Children,s Hospital Medical Center....
Other Biology News:'Scrawny' gene keeps stem cells healthy 2NYU scientists discover dangerous new method for bacterial toxin transfer 2NYU scientists discover dangerous new method for bacterial toxin transfer 3NYU scientists discover dangerous new method for bacterial toxin transfer 4Genetic mutation causes familial susceptibility for degenerative brain disease 2Genetic mutation causes familial susceptibility for degenerative brain disease 3
...um atoms at the 3, 3', 4, and 4' positions. It is ...uantification of Prostaglandin E2 (PGE2) by GC- or...cyclooxygenase products of arachidonic acid and on...Its activity influences inflammation, fertility an...
Agarose Gel Loading Dye Mixture 6X (with ficoll) from GenScript Corporation
Site-directed DNA Mutagenesis Service from Yorkshire Bioscience Ltd
Treponema Pallidum Total ELISA Kit, Single from Bio-Quant Inc.
Biology Products: